Centre for the Commercialization of Regenerative Medicine / Centre de commercialisation de la médecine régénérative

---

Registration: 12 of 14 (2025-06-23 to 2026-03-15)

Details Regarding the Identified Subject Matter

Subject matters	Details	Categories
Economic Development, Employment and Training, Health, Regional Development, Research and Development, Science and Technology	Seeking support from the Strategic Innovation Fund to support application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty.	Policies or Program, Grant, Contribution or Other Financial Benefit